[Repigmentation in vitiligo universalis triggered by hemodialysis]

Area of Science:

• Dermatology
• Nephrology
• Autoimmune disorders

Background:

• Vitiligo is an acquired depigmenting disorder with unknown pathogenesis.
• Vitiligo universalis, a rare subtype, causes extensive skin depigmentation and significant aesthetic concerns.
• Current treatments for vitiligo universalis are challenging and often focus on depigmented areas.

Observation:

• A patient with a long-standing history of stable vitiligo universalis was initiated on hemodialysis.
• The patient experienced spontaneous repigmentation of the depigmented skin areas shortly after commencing hemodialysis treatment.

Findings:

• The initiation of hemodialysis was temporally associated with the onset of repigmentation in vitiligo universalis.
• This observation suggests a potential, previously undocumented, effect of hemodialysis on vitiligo skin repigmentation.

Implications:

• Hemodialysis may influence the autoimmune or cellular processes underlying vitiligo.
• Further research is warranted to explore the mechanisms connecting renal replacement therapy and vitiligo repigmentation.
• This finding could open new avenues for vitiligo management strategies.